TickerFacts.

ARS Pharmaceuticals, Inc. (SPRY): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.37M
Year ended 2025-12-31
$1.62M
Trailing 12 months to 2026-06-30
2022-12-31: $100.0K2023-12-31: $100.0K2024-12-31: $79.0K2025-12-31: $1.37M$1.37M
2022-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$1.37Mn/m2026-03-09, From 2025-01-01
2024-12-31$79.0Kn/c2026-03-09, From 2024-01-01
2023-12-31$100.0K0.0%2025-03-20, From 2023-01-01
2022-12-31$100.0Kn/a2024-03-21, From 2022-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
ARS Pharmaceuticals, Inc. (SPRY)2025-12-31$1.37Mn/m
Nurix Therapeutics, Inc. (NRIX)2025-11-30$8.74M-6.2%
Standard Biotools Inc. (LAB)2025-12-31$9.26M-26.0%
Arcturus Therapeutics Holdings Inc. (ARCT)2025-12-31$3.02M-14.6%
Cytokinetics Inc (CYTK)2025-12-31$10.12M+6.2%
Eton Pharmaceuticals, Inc. (ETON)2025-12-31$4.04M+252.9%
Siga Technologies Inc (SIGA)2025-12-31$562.6K+4.5%
Bicycle Therapeutics PLC (BCYC)2025-12-31$6.42M-10.5%
Assembly Biosciences, Inc. (ASMB)2025-12-31$129.0K0.0%

Compare SPRY, NRIX, LAB, ARCT side by side · Screen every company in Pharmaceutical Preparations ↗